Alterity Therapeutics Announces Granting of New Composition of Matter Patent and Exclusive License Agreement for Assets in Alzheimer’s Disease March 14, 2023May 23, 2023
Alterity Therapeutics Announces Presentation of Wearable Sensor Data from the bioMUSE Natural History Study at the International Congress of Parkinson’s Disease and Movement Disorders September 26, 2022May 23, 2023
Alterity Therapeutics Presents New Data on Multiple System Atrophy, a Rare Parkinsonian Disorder August 31, 2023August 31, 2023
